Abivax (ABVX) EPS (Basic) (2024 - 2026)

Abivax (ABVX) recorded quarterly EPS (Basic) of -$0.06 in Q1 2026, up 37.3% quarter-over-quarter from -$0.1 in Q4 2025, and up 92.64% on a YoY basis from -$0.03 in Q1 2025.

Abivax (ABVX) EPS (Basic) (2024 - 2026) Analysis & Trends

Abivax's EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.06 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 92.64% year-over-year to -$0.06; the TTM figure through Mar 2026 stood at -$0.43 (up 100.0% YoY), while the FY2025 annual figure was -$5.62, down 87.91% from the prior year.
  • EPS (Basic) was -$0.06 for Q1 2026 at Abivax, up from -$0.1 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.06 in Q1 2026 to a low of -$63039.7 in Q1 2024.
  • Historically, EPS (Basic) has averaged -$10318.4 across 3 years, with a median of -$0.62 in 2024.
  • Biggest YoY gain for EPS (Basic) was 100.0% in 2025; the steepest drop was 77.43% in 2025.
  • A 3-year view of EPS (Basic) shows it stood at -$0.62 in 2024, then jumped by 84.45% to -$0.1 in 2025, then jumped by 37.3% to -$0.06 in 2026.
  • The last three EPS (Basic) figures came in at -$0.06 (Q1 2026), -$0.1 (Q4 2025), and -$0.2 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -0.68
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 3.06
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.00
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 0.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 0.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 0.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 4.06
9 Abivax 94.26 Bn 94.26 Bn - -0.06
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn 6.99

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.06
Dec 31, 2025 -0.10
Sep 30, 2025 -0.20
Jun 30, 2025 -0.08
Mar 31, 2025 -0.83
Dec 31, 2024 -0.62
Sep 30, 2024 -0.87
Jun 30, 2024 -29,823.08
Mar 31, 2024 -63,039.71